tm
Seeing Is Believing
tm
Seeing Is Believing
NVCT is currently covered by 1 analysts with an average price target of $14.03. This is a potential upside of $5.04 (56.06%) from yesterday's end of day stock price of $8.99.
Nuvectis Pharma's activity chart (see below) currently has 5 price targets and 9 ratings on display. The stock rating distribution of NVCT is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 11.11% with an average time for these price targets to be met of 65 days.
Highest price target for NVCT is $15, Lowest price target is $15, average price target is $15.
Most recent stock forecast was given by JOSEPH PANTGINIS from HC WAINWRIGHT on 29-Apr-2025. First documented stock forecast 01-Mar-2022.
Currently out of the existing stock ratings of NVCT, 5 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$15
$6.01 (66.85%)
$11
11 days ago
(29-Apr-2025)
1/9 (11.11%)
$5.04 (50.60%)
65
What is NVCT (Nuvectis Pharma) average time for price targets to be met?
Which analyst has the current highest performing score on NVCT (Nuvectis Pharma) with a proven track record?
Which analyst has the most public recommendations on NVCT (Nuvectis Pharma)?
Which analyst is the currently most bullish on NVCT (Nuvectis Pharma)?
